Targeting Obesity for the Prevention of Chronic Cardiovascular Disease Through Gut Microbiota-Herb Interactions: An Opportunity for Traditional Herbs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|8|1142-1152

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.8, 2017-04, pp. : 1142-1152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease

By  

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1324-1331

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting platelets for prevention and treatment of cardiovascular disease

By Duhamel Todd A   Xu Yan-Jun   Arneja Amarjit S   Dhalla Naranjan S  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1523-1533

Informa Healthcare

Access to resources Recommend Favorite

The Gut Microbiota in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1528-1536

Bentham Science Publishers

Access to resources Recommend Favorite

Interplay of Gut Microbiota, Probiotics in Obesity: A Review

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 3, 2018-04 ,pp. : 212-220

Bentham Science Publishers

Access to resources Recommend Favorite

Investigation of Chitosan for Prevention of Diabetic Progression Through Gut Microbiota Alteration in Sugar Rich Diet Induced Diabetic Rats

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 2, 2016-02 ,pp. : 173-184

Bentham Science Publishers

Access to resources Recommend Favorite